EFTA01841646

To: Cc: Lesley Gro From: Jeffrey epstein Sent: Thur 2/9/2012 1:10:40 PM Subject: Re: Hi Jeffrey 5? Sorry for all the typos .Sent from my iPhonc On Feb 9, 2012, at 8:31 AM, <a> wrote: can set set an approximate time? Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston, MA 02215 Ph on Email: Web: www.prociraminplacebostudies.org On Feb 7, 2012, at 2:27 PM, Jeffrey Epstein wrote: ped martin novak On Tuc, Feb 7, 2012 at 3:25 PM, •cawrote: what time? any office if at I Brattic Sq. ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston, MA 02215 EFTA_R1_00228094 EFTA01841646 Email: Web: www.proqraminplacebostudies.org On Feb 7, 2012, at 2:22 PM, Jeffrey Epstein wrote: 1 brattle square On Tuc, Fcb 7, 2012 at 3:12 PM, dc: > wrote: Jeffrey, I think it may be a good idea to set up a time to meet on April 12 in Cambridge. As a location, I can offer my home office near Harvard Sq, my office at the medical school, or any tea shop in the area. Or do you have another preference? Suggest a time as I'm flexible that day. ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston. MA 02215 Phone: Email: Web: www.prociraminplacebostudies.orq On Fcb 6, 2012, at 5:53 PM, Jcffrcy Epstein wrote: EFTA_R1_00228095 EFTA01841647 eambridge april 12, but phone availble before On Mon, Feb 6, 2012 at 5:15 PM, ‹ > wrote: Hi Jeffrey, When is a good time to talk about placebo? When are you next in Cambridge? ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Bosto Phone: Email: Web: www.programinplacebostudies orq On Jan 13, 2012, at 3:15 PM, Jeffrey Epstein wrote: Im in africa until the 27th u> wrote: On Fri, Jan 13, 2012 at 9:05 PM, Hi Jeff, I'm around Monday, Martin Luther King day until 3pm. Is that a good day for a phone conversation? EFTA_R1_00228096 EFTA01841648 Alternatively, as the phone hasn't been too successful, should we meet in person? When are you in Cambridge next? ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston. MA 0221 Phone: Email: Web: www.proeraminplacebostudies.orq On Dec 25, 2011, at 1:31 PM, Jeffrey Epstein wrote: On Sun, Dec 25, 2011 at 2:04 PM, lets alk on tuts > wrote: Is there a good time to cheekin with you to get your feedback on the budget we EFTA_R1_00228097 EFTA01841649 sent you two weeks ago and on what issues would interest you in developing a partnership with our efforts in placebo studies? We're trying to think bot scientifically and strategically. Our team has all the intellectual and infrastructure resources of Harvard University and any input would be appreciated. Best, ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston MA 02215 Phone: Email: EFTA_R1_00228098 EFTA01841650 Web: www.prociraminplacebostudies.orq On Dec 5, 2011, at 2:41 PM, Jeffrey Epstein wrote: no w 9 On Mon, Dec 5, 2011 at 1:26 PM, wr of C: EFTA_R1_00228099 EFTA01841651 ie d c al li n g y 0 u 0 n N 0 v e m b c r 2 8 N 0 a n s w e r. Our work is getting enormous media attention. ( A tt a C h e d is a n a rt EFTA_R1_00228100 EFTA01841652 is Ic in hi k' N Y 0 r k r. is d it a d f 0 d m 0 0 n 0 EFTA_R1_00228101 EFTA01841653 ci n C C d le 0 n m e. C x C ct V C r 0 b 0 M in to in a EFTA_R1_00228102 EFTA01841654 n r Y• This is a critical time to develop our scientific and in st it ti 0 n al r 0 0 is at H r r d c' r 0 0 ki 0 r p n rt EFTA_R1_00228103 EFTA01841655 n rs 0 cl 0 V 0 r c c m r al 0 n 0 ul r b d 0 EFTA_R1_00228104 EFTA01841656 r ti m e y 0 u c 0 ul d to lk b y te le p h 0 n e 9 Best ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic E n c 0 u n te r Beth Israel Deaconess Medical Center Boston MA 02215 Phone: Email: Web: www.programinplacebostudies.org EFTA_R1_00228105 EFTA01841657 ** [repeated 8 times] * The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only fo r the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly pr oh ibi to d and may be unlawful. If you have received this communication in error, please notify us im m cd iat el by return e-mail or by e-mail to jet! EFTA_R1_00228106 EFTA01841658 si fig n g m ail .c 0 an d destroy this communication and all copies thereof, including all attachments. copyright -all rights re se ry ed The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jc fac z gmail.com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA_R1_00228107 EFTA01841659 The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return c-mail or by e-mail to jecvacation@gmail.com and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved ii The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. if you have received this communication in error, please notify us immediately by return c-mail or by e-mail to jeevacati n mail.com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this EFTA_R1_00228108 EFTA01841660 communication in error, please notify us immediately by return e-mail or by e-mail to jeevacation@gmail.com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jeevacation@gmail.com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA_R1_00228109 EFTA01841661